FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.
UC San Diego researchers have found a stem cell enzyme copy edits more than 20 tumor types, providing new therapeutic target for preventing cancer cell resistance to chemotherapy and radiation.
Moderate to severe loneliness can persist across adult lifespans, but UC San Diego School of Medicine researchers found it is particularly acute in three age periods: late-20s, mid-50s and late-80s. Wisdom proved a protective factor.
UC San Diego researchers join national effort to better understand human immune system as part of new Allen Institute of Immunology.
Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.
New UC San Diego campaign promotes sexual health and has a quick test to prove it. “Good to Go” offers combined testing for HIV and five sexually transmitted diseases, providing some results in as little as 60 seconds and access to free treatment, if needed. Updated clinic opening Dec. 10.
High-tech surgical suites allow doctors to scan patients without either leaving the operating room.
Researchers find that specific complex breast milk sugars sometimes inhibit, sometimes promote gastrointestinal infections and response.
Differential brain responses to speech in toddlers with autism and poor language development associated with widespread gene expression activity in blood leukocyte cells.
Researchers at University of California San Diego School of Medicine with colleagues at the National Institutes of Health and UC San Francisco report finding infectious agent in the eyes of deceased sCJD patients, making the eye a potential source for early CJD detection and prevention of disease.